Proteon Therapeutics to Present at the Oppenheimer 25th Annual Healthcare Conference December 11th
08 déc. 2014 08h00 HE
|
Proteon Therapeutics, Inc.
WALTHAM, Mass., Dec. 8, 2014 (GLOBE NEWSWIRE) -- Proteon Therapeutics Inc. (Nasdaq:PRTO), a company developing novel, first-in-class pharmaceuticals to address the medical needs of patients with...
Proteon Therapeutics Announces Third Quarter 2014 Financial Results
25 nov. 2014 08h00 HE
|
Proteon Therapeutics, Inc.
WALTHAM, Mass., Nov. 25, 2014 (GLOBE NEWSWIRE) -- Proteon Therapeutics Inc. (Nasdaq:PRTO), a company developing novel, first-in-class pharmaceuticals to address the medical needs of patients with...
Proteon Therapeutics Announces the Closing of Initial Public Offering and the Underwriters' Option to Purchase Additional Shares
24 nov. 2014 08h00 HE
|
Proteon Therapeutics, Inc.
WALTHAM, Mass., Nov. 24, 2014 (GLOBE NEWSWIRE) -- Proteon Therapeutics Inc. (Nasdaq:PRTO), a company developing novel, first-in-class pharmaceuticals to address the medical needs of patients with...
Proteon Therapeutics Announces Pricing of Initial Public Offering
21 oct. 2014 19h36 HE
|
Proteon Therapeutics, Inc.
WALTHAM, Mass., Oct. 21, 2014 (GLOBE NEWSWIRE) -- Proteon Therapeutics Inc., a company developing novel, first-in-class pharmaceuticals to address the medical needs of patients with kidney and...
Blood Purification Technologies Announced That the FDA Approved the First US Trial of the Wearable Artificial Kidney
11 févr. 2014 15h09 HE
|
Blood Purification Technologies Inc.
ATLANTA, Feb. 11, 2014 (GLOBE NEWSWIRE) -- The U.S. Food & Drug Administration has approved the start of the first human clinical trials in the United States for the Wearable Artificial Kidney...